These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 18057655)

  • 1. [Parathyroid and bone. Skeletal derangement in patients with primary hyperparathyroidism].
    Takeuchi Y
    Clin Calcium; 2007 Dec; 17(12):1815-21. PubMed ID: 18057655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism.
    VanderWalde LH; Liu IL; O'Connell TX; Haigh PI
    Arch Surg; 2006 Sep; 141(9):885-9; discussion 889-91. PubMed ID: 16983032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in calcium metabolism after parathyroidectomy in primary hyperparathyroidism].
    Berczi C; Balogh A; Balázs G; Lukács G
    Orv Hetil; 2002 Mar; 143(12):597-600. PubMed ID: 11963396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in bone mineral density after surgical intervention for primary hyperparathyroidism.
    Dy BM; Grant CS; Wermers RA; Kearns AE; Huebner M; Harmsen WS; Thompson GB; Farley DR; Richards ML
    Surgery; 2012 Dec; 152(6):1051-8. PubMed ID: 23040710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary osteoporosis UPDATE. Primary hyperparathyroidism].
    Tominaga Y
    Clin Calcium; 2010 May; 20(5):728-34. PubMed ID: 20445284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Absolute risk for fracture and WHO guideline. Treatment of patients with secondary osteoporosis].
    Yamauchi M;
    Clin Calcium; 2007 Jul; 17(7):1106-13. PubMed ID: 17607079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parathyroid hormone for osteroporsis: why and who to treat?].
    Ferrari S; Rizzoli R
    Rev Med Suisse; 2005 Oct; 1(35):2272-4, 2276-7. PubMed ID: 16268450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hyperparathyroidism and the skeleton.
    Mosekilde L
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of primary hyperparathyroidism in the management of osteoporosis.
    Saleem TF; Horwith M; Stack BC
    Otolaryngol Clin North Am; 2004 Aug; 37(4):751-61, viii-ix. PubMed ID: 15262513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parathyroid and bone. The mechanism of anabolic function of parathyroid hormone on bone].
    Ogata N; Kawaguchi H
    Clin Calcium; 2007 Dec; 17(12):1843-9. PubMed ID: 18057659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet for the treatment of primary hyperparathyroidism.
    Dillon ML; Frazee LA
    Am J Ther; 2011 Jul; 18(4):313-22. PubMed ID: 20228675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic primary hyperparathyroidism: surgical and medical management.
    Francucci CM; Ceccoli L; Caudarella R; Rilli S; Vescini F; Boscaro M
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):50-4. PubMed ID: 21985981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.
    Lewiecki EM
    J Clin Densitom; 2010; 13(4):324-34. PubMed ID: 21029971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cohort study of fracture risk before and after surgery of primary hyperparathyroidism].
    Vestergaard P; Mollerup CL; Frøkjaer VG; Christiansen PM; Blichert-Toft M; Mosekilde L
    Ugeskr Laeger; 2001 Sep; 163(36):4875-8. PubMed ID: 11571864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal effects of combined medical and surgical management of primary hyperparathyroidism.
    Orr LE; Zhou H; Zhu CY; Haigh PI; Adams AL; Yeh MW
    Surgery; 2020 Jan; 167(1):144-148. PubMed ID: 31582307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation of bone mass determinations as they relate to fracture: implications for asymptomatic primary hyperparathyroidism.
    Peacock M
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S77-82; discussion S83-4. PubMed ID: 1763673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New development in bisphosphonate treatment. Clinical significance of combinatorial therapies with bisphosphonates and parathyroid hormone for osteoporosis].
    Takeuchi Y
    Clin Calcium; 2009 Jan; 19(1):85-90. PubMed ID: 19122268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs.
    Adler RA; Hochberg MC
    Arch Intern Med; 2003 Nov; 163(21):2619-24. PubMed ID: 14638562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.